156 related articles for article (PubMed ID: 38406957)
1. Post Renal Transplant Malignancies; A Basic Concept.
Nabi Z; Zahid T; Nabi R
J Ayub Med Coll Abbottabad; 2023; 35(4):664-668. PubMed ID: 38406957
[TBL] [Abstract][Full Text] [Related]
2. Post-renal transplant malignancies: Opportunities for prevention and early screening.
Turshudzhyan A
Cancer Treat Res Commun; 2021; 26():100283. PubMed ID: 33338850
[TBL] [Abstract][Full Text] [Related]
3. Malignancy following renal transplantation.
Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
Gutierrez-Dalmau A; Campistol JM
Drugs; 2007; 67(8):1167-98. PubMed ID: 17521218
[TBL] [Abstract][Full Text] [Related]
5. De-novo malignancies after kidney transplantation: A long-term observational study.
Fröhlich FA; Halleck F; Lehner L; Schrezenmeier EV; Naik M; Schmidt D; Khadzhynov D; Kast K; Budde K; Staeck O
PLoS One; 2020; 15(11):e0242805. PubMed ID: 33253202
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of de novo malignancies after solid-organ transplantation: immunosuppression, infection and other risk factors.
Piselli P; Verdirosi D; Cimaglia C; Busnach G; Fratino L; Ettorre GM; De Paoli P; Citterio F; Serraino D
Best Pract Res Clin Obstet Gynaecol; 2014 Nov; 28(8):1251-65. PubMed ID: 25209964
[TBL] [Abstract][Full Text] [Related]
7. Postrenal transplant malignancy: Incidence, risk factors, and prognosis.
Elserwy NA; Lotfy EE; Fouda MA; Mahmoud MI; Donia AF; Mashaly ME; Abbas MH; Abuelmagd MM; Abouelenein RK; Ismail MI; Bakr MA
Saudi J Kidney Dis Transpl; 2017; 28(3):579-588. PubMed ID: 28540896
[TBL] [Abstract][Full Text] [Related]
8. [Skin cancers in kidney transplant recipients].
Bieryło A; Brzósko S; Laudańska E; Naumnik B
Wiad Lek; 2017; 70(1):68-73. PubMed ID: 28343197
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of malignancies after kidney transplantation in adults: Slovak multicenter experience.
Zilinska Z; Sersenova M; Chrastina M; Breza J; Bena L; Baltesova T; Jurcina A; Roland R; Lackova E; Cellar M; Laca L; Dedinska I
Neoplasma; 2017; 64(2):311-317. PubMed ID: 28052685
[TBL] [Abstract][Full Text] [Related]
10. [Skin cancer in renal transplant recipients].
Mangino M; Schena FP
G Ital Nefrol; 2010; 27 Suppl 50():S75-80. PubMed ID: 20922700
[TBL] [Abstract][Full Text] [Related]
11. Tumours after kidney transplantation.
Lutz J; Heemann U
Curr Opin Urol; 2003 Mar; 13(2):105-9. PubMed ID: 12584469
[TBL] [Abstract][Full Text] [Related]
12. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
13. Early diagnosis of cancer in renal transplant patients: a single center experience.
Yildirim Y; Ozyilkan O; Emiroglu R; Demirhan B; Karakayali H; Haberal M
Asian Pac J Cancer Prev; 2006; 7(2):336-9. PubMed ID: 16839235
[TBL] [Abstract][Full Text] [Related]
14. Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.
Braconnier P; Del Marmol V; Broeders N; Kianda M; Massart A; Lemy A; Ghisdal L; Le Moine A; Madhoun P; Racapé J; Abramowicz D; Wissing KM
Nephrol Dial Transplant; 2012 Jun; 27(6):2547-53. PubMed ID: 22123748
[TBL] [Abstract][Full Text] [Related]
15. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
16. Malignancies in organ transplant recipients.
Hoshida Y; Aozasa K
Pathol Int; 2004 Sep; 54(9):649-58. PubMed ID: 15363032
[TBL] [Abstract][Full Text] [Related]
17. Comparison of demographic data and immunosupression protocol in patients with and without malignancy after kidney transplantation.
Akbarzadehpasha A; Oliaei F; Asrari MR; Alizadeh-Navaei R
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1044-7. PubMed ID: 21060171
[TBL] [Abstract][Full Text] [Related]
18. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
19. Malignancy in kidney transplant recipients.
Kapoor A
Drugs; 2008; 68 Suppl 1():11-9. PubMed ID: 18442297
[TBL] [Abstract][Full Text] [Related]
20.
Al-Adra D; Al-Qaoud T; Fowler K; Wong G
Clin J Am Soc Nephrol; 2022 Mar; 17(3):434-443. PubMed ID: 33782034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]